Streetbeat News

Revenues

FWRG

First Watch Restaurant Group (FWRG) projects FY23 same-restaurant sales growth of 7%-8%, revenue growth of 20%-21%, and adjusted EBITDA of $91M-$92M.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:32 pm

LEXX

Lexaria Bioscience Corp. (NASDAQ:LEXX) is expanding its studies of its proprietary DehydraTECH platform in the GLP-1 drug space, a market estimated to reach $82.93 billion by 2027. The company's early studies in 2022 showed positive effects of lowering glucose levels, body weight, and triglyceride levels, and increased locomotor activity.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:31 pm

FRSX

Foresight Autonomous Holdings Ltd. (FRSX) is focusing on defense, industrial vehicles, and Eye-Net Mobile initiatives in the short term. The company has signed several agreements and achieved milestones in these sectors, including a $4 million deal with Elbit Systems and a $51 million deal with SUNWAY-AI Technology. Foresight is also pursuing projects in the automotive industry, with partnerships with Hitachi Astemo and ZF Friedrichschafen. The company's Eye-Net subsidiary has partnered with SoftBank and received an order from a leading Japanese vehicle manufacturer.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:28 pm

SRAD

Sportradar Group has projected its FY23 revenue to be between €870M-€880M, representing a YoY increase of 19%-21%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:24 pm

CDAY

Ceridian HCM has issued its Q4 and FY23 guidance, expecting revenues of $398M-$401M and $1.512B-$1.515B respectively, both exceeding estimates. The company anticipates an 18%-19% increase in Q4 revenue and a 21%-22% increase in FY23 revenue. Dayforce recurring revenue is expected to grow by 29%-30% in Q4 and 28% in FY23. Tax migration from legacy infrastructure to the Dayforce platform is expected to contribute significantly to growth.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:23 pm

OSW

OneSpaWorld (OSW) has projected its Q4 2023 revenue to be between $193M and $198M, which is slightly below the estimated $197.43M.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:22 pm

CVX

DWSN

SDRL

WKC

Four energy stocks, Chevron Corporation (CVX), Dawson Geophysical Company (DWSN), World Kinect Corporation (WKC), and Seadrill Limited (SDRL), are identified as oversold with their Relative Strength Index (RSI) values below 30, indicating potential for short-term growth. CVX reported weaker Q3 earnings, DWSN reported increased revenues for Q2 2023, WKC posted better-than-expected quarterly sales, and SDRL reported a Q2 operating revenue of $414 million.

Portfolio Pulse from Lisa Levin

November 01, 2023 | 12:21 pm

OSW

OneSpaWorld (OSW) has increased its FY23 revenue forecast from $770M-$790M to $792M-$797M, compared to the estimated $790.64M.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:20 pm

LIVN

LivaNova has projected its FY23 revenue growth to be between 9% and 11% on a constant-currency basis.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:14 pm

LGND

SNY

Ligand Pharmaceuticals has acquired Tolerance Therapeutics for $20M in cash. Tolerance Therapeutics is a holding company that is owed a royalty of less than 1% on worldwide net sales of Tzield (Teplizumab), which is marketed by Sanofi. The transaction will be immediately accretive to Ligand's royalty revenue.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:06 pm